title: Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
abstract: Colorectal cancer is the second most common cause of cancer death in much of the developed world. Cancer-related mortality is slowly decreasing as a result of better detection and improved surgery. Adjuvant chemotherapy is now considered the standard treatment for stage III colon cancer, and has evolved recently with the introduction of infusional, combination chemotherapy. Adjuvant therapy for stage II colon cancer has been more controversial. Recent trial data suggest, however, that there is a legitimate case for discussing the advantages and limitations with individual patients.
authors.affiliation: Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, Oxford, UK.
authors.forename: Rachel
authors.initials: R
authors.lastname: Midgley
authors.forename: David J
authors.initials: DJ
authors.lastname: Kerr
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant / Q000266:history; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D049673:History, 20th Century; D006801:Humans; D009367:Neoplasm Staging